Navigation Links
First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval
Date:7/22/2008

Test Developed and Validated by Columbia University Medical Center Based on

Rosetta Genomics' Proprietary MicroRNA Technology The Test Differentiates Squamous From Non-Squamous Non-Small Cell Lung

Cancer (NSCLC), Classifying Squamous-Cell Carcinoma of the Lung With

Sensitivity of 96 Percent and Specificity of 90 Percent This is the First CLIA Approved Test Which Leverages MicroRNAs' Sensitivity

as Biomarkers for Accurate Diagnosis of Lung Cancer

REHOVOT, Israel and JERSEY CITY, New Jersey, July 22 /PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (NASDQ: ROSG) announces today that the first molecular test based on Rosetta Genomics' proprietary microRNA technology, developed and validated by Columbia University Medical Center (CUMC), has been approved for clinical use by the New York State Department of Health Clinical Laboratory Evaluation Program. CUMC is now finalizing the commercial aspects of this test and will announce its clinical availability to patients nationwide once details are finalized later this year.

"This is a landmark event for us, marking the first step in the transformation of Rosetta Genomics into a commercial diagnostics company," said Amir Avniel, President and CEO of Rosetta Genomics. "Our proprietary microRNA platform technologies, which this test is based on, have enabled Columbia University Medical Center's High Complexity Molecular Pathology Laboratory to develop a highly sensitive and specific test, which is a key for optimal administration of targeted therapies for this devastating cancer. As we move forward, we expect our development engines to enable the launch of additional tests based on our technology that have the potential to improve patient care worldwide."

The test, performed on a sample of a patient's tumor, classifies squamous-cell carcinoma of the lung with sensitivity of 96 percent and specificity of 90 percent. This is the first test utilizing microRNA
'/>"/>

SOURCE Rosetta Genomics Ltd
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Ekkyo Describes the First Benefits of Controlled Hyperthermia in Humans in "Lasers in Surgery and Medicine"
2. Wacker Validates Scalability of Anticalin(R) Production With E.coli Secretion Technology and Will Produce Pieris First Clinical Candidate PRS-050
3. Bapineuzumab To Become the First-to-Market Disease-Modifying Alzheimers Drug After Flurizans Discontinuation
4. Insmed Announces First Human Bioequivalence Data for a Follow-on Biologic by a U.S. Company
5. Sonablate(R) International HIFU Registry is the First Worldwide HIFU Clinical Registry for Prostate Cancer Treatments
6. Patient Receives vProtect(TM) Luminal Shield in First-Ever Vulnerable Plaque Clinical Trial
7. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
8. First Breast Cancer Patient Receives Treatment in National Electronic Brachytherapy Registry Launched by Three Physician Societies
9. Olanzapine Long-Acting Injection (LAI) Data Presented at First Annual Schizophrenia International Research Society Conference
10. Accumetrics Announces the Launch and First Patient Enrolled Into the GRAVITAS Trial
11. Fox Chase Cancer Center and VisEn Medical Announce Program to Advance First Clinical Trials of Novel Fluorescence Molecular Imaging Technologies

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...re/--RegadoBiosciences,aprivatelyheldcompanyleadin...ontrolagents,announcedthatDavidMazzo,PhD,CEOandPre...HealthCareConferenceattheNewYorkPalaceHotelinNewYo...ST)onTuesday,December1andwillincludeanoverviewofth...program,theanticoagulantsystem,REG1.Thehealthcarei...
(Date:11/25/2009)...e-FirstCall/--Abaxis,Inc.(Nasdaq: ABAX ),amedicalp...sissystems,announcedtodaythatClintSeverson,chairma...alPiperJaffrayHealthCareConferenceonWednesday,Dece...eNewYorkPalaceHotelinNewYorkCity. ,, AboutAbax...tablebloodanalysissystemsforuseinanyveterinaryorhu...
(Date:11/25/2009).../--CempraPharmaceuticalsInc.todayannouncedthatPrab...,willpresentatthePiperJaffray21stAnnualHealthCareC...PalaceHotelinNewYorkCity.Dr.Fernandeswillprovidean...programsforthetreatmentofdrug-resistantpathogensin..., Foundedin2006,CempraPharmaceuticalsisaprivatel...
Breaking Medicine Technology:Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2LA BioMed to honor Emil D Kakkis M D Ph D and LA County Supervisor Don Knabe 58426 1LA BioMed to honor Emil D Kakkis M D Ph D and LA County Supervisor Don Knabe 58426 2Global public health the focus of scientific conference 10144 1Global public health the focus of scientific conference 10144 2Clot Busting Therapy Under Review 58424 1Clot Busting Therapy Under Review 58424 2Clot Busting Therapy Under Review 58424 3
...INACH, Switzerland, October 14 Arpida Ltd.,(SWX: ...from the U.S. Food,and Drug Administration (FDA) t...mittee will discuss the New Drug Application (NDA)...Skin Structure Infections,(cSSSI) during its meeti...an be requested by FDA as part of the review proce...
...w 1.5 million dollar NIH funding advances study ...vival rates, MINNEAPOLIS, Oct. 13 Advanced Circu...ory.com ) announced today that it has received,an ...al Institutes of,Health (NIH) to continue a study ...ho experience cardiac arrest outside a hospital. W...
Other Medicine Technology:Arpida Announces Review of Iclaprim NDA by FDA Advisory Committee in November 2008 2Arpida Announces Review of Iclaprim NDA by FDA Advisory Committee in November 2008 3Whatcom County, Washington Participating in NIH Study of Cardiac Arrest Resuscitation Techniques 2
(Date:11/26/2009)... a bigger thrill when on an emotional rollercoaste...althDay News) -- Call it the fear factor meets the...at spectators -- especially those who root for the...f it,s a closely contested match and victory was i...air. , Chew on that this Thanksgiving weekend a...
(Date:11/26/2009)... Research Triangle Dental (RTDent...rth Carolina, today announced the expansion of its...NEER Dentist, Dr. Doug Macmillan. , ...gle Dental is pleased to announce that Dr. Doug Ma...tly completed an additional advanced training semi...
(Date:11/25/2009)...EDINA,Minn.,Nov.25/PRNewswire-USNewswire/--Whenmos...utachiropractorcanalsogivepatientsthehelptheyneed....reyourjaw(mandible)contacts/connectswithyourskull(...edwithTMJdysfunctionarepainwithchewing,clickingorp...TMJdysfunctionincluding:headaches,fatigue,sleepdis...
(Date:11/25/2009)...TORONTOandCALGARY,Nov.25/PRNewswire/-SentinelleMed...aging(MRI)coilsandsoftwareandCalgaryScientificInc....veintroducedawebversionofAegis(TM)Breast4DAdvanced...ceisthefirsttrulyzero-footprintWebclientbasedmedic...reWeb(TM)platformallowsforzero-footprintaccess-req...
(Date:11/25/2009)...SILVERSPRING,Md.,Nov.25/PRNewswire-USNewswire/--An...erforDrugEvaluationandResearch,titled"ADifficultBa...intheNov.26,2009issueofTheNewEnglandJournalofMedic...rnh/20090824/FDALOGO ) ,, Inthearticle,Woodcock...painmedicationforthosewhoneeditandmanagingtherisks...
Breaking Medicine News(10 mins):Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3
...eems that Paris Hilton is making all possible arra...rison interview. According to sources, th...ng released on June 26, is pamper her dry face. ...ing dry. So, the heiress has booked a faci...
...ents with radiation retinopathy who were destined ...ight longer through localized treatment with Avast...year study published in the June, 2007 Archives of...nopathy, said Paul T. Finger, MD, lead author of t...
...thousand turkeys at a Czech farm where the potenti...this week have been slaughtered, officials said on...en killed and the process is underway for the smal...Friday)," he added. The H5N1 strain of bird fl...
...ue fever has infected almost 20,000 people in Viet... 21, seven more than in the same period last year,...eratures and rainfalls have been blamed for the ne...lta. Malaysia and other Southeast Asian count...
...archers have formed a new compound AN2690, that mi...in nails by blocking an enzyme crucial for the pro...udy was conducted by a team of researchers includi...oble, France. AN2690 interferes with an enz...
...force, an Anglo-American company has been allowed ...ases in future by the US Food and Drug Administrat...ells of the immune system that defend the body aga...s and will extract the white blood cells to store ...
Other Medicine News:Health News:Untreatable Eye Disease Improves With Avastin 2Health News:Researchers Devise New Compound to Treat Fungal Infections 2
SLM 5000 Autolensmeter
...bjective nature of manual lensmeter readings, redu...ctive measurements every time. The easy to read, h...ystem ensure fast and simple operation. On-screen...oning and, in auto mode, users can make a complete...
...gned for fast & easy operation. The 5.7 inch color...ne., ,In AUTO mode, the readings are automatic...-Focal lenses are automatically detected by TL-300...sition the lens. The color touch panel display is ...
KOWA nonmyd 7 / VK-2 Digital Imaging System
Medicine Products: